# China NMPA Drug Inspection - Shenzhen Jiurui Health Technology Development Co., Ltd.; Contractor: Sinopharm Group Guangdong Global Pharmaceutical Co., Ltd. - Benorilate tablets

Source: https://www.globalkeysolutions.net/records/china_drug_inspection/shenzhen-jiurui-health-technology-development-co-ltd-contractor-sinopharm-group-guangdong-global-pharmaceutical-co-ltd/761263bc-e1fc-4a2b-87d5-886002894dd7/
Source feed: China

> China NMPA drug inspection for Shenzhen Jiurui Health Technology Development Co., Ltd.; Contractor: Sinopharm Group Guangdong Global Pharmaceutical Co., Ltd. published June 17, 2021. Drug: Benorilate tablets. 

---

## Details

- Record Type: CHINA_DRUG_INSPECTION
- Title: Guangdong Provincial Drug Administration's Announcement Regarding Drug Sampling and Inspection Information (Issue 4, 2021)
- Company Name: Shenzhen Jiurui Health Technology Development Co., Ltd.; Contractor: Sinopharm Group Guangdong Global Pharmaceutical Co., Ltd.
- Publication Date: 2021-06-17
- Drug Name: Benorilate tablets
- Inspection Finding: Meets the requirements of drug standards (qualified)
- Action Taken: It does not involve the investigation and handling of substandard drugs.

Company: https://www.globalkeysolutions.net/companies/shenzhen-jiurui-health-technology-development-co-ltd-contractor-sinopharm-group-guangdong-global-pharmaceutical-co-ltd/434a62b7-23c0-4f26-a193-50250d822ee3/